Bosentan Tablet
FDA Label NDC 70771-1017

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Bosentan (NDC 70771-1017). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1017-6

Bosentan tablets, 62.5 mg

60 tablets

Rx only

Bosentan Tablets (2e308f6b 6088 43b6 A8ed 191a3117a45f 01)

Bosentan Tablets (2e308f6b 6088 43b6 A8ed 191a3117a45f 01)

NDC 70771-1018-6

Bosentan tablets, 125 mg

60 tablets

Rx only

Bosentan Tablets (2e308f6b 6088 43b6 A8ed 191a3117a45f 02)

Bosentan Tablets (2e308f6b 6088 43b6 A8ed 191a3117a45f 02)

* Please review the disclaimer below.